Madrigal S-NASH-es Monday’s Trading

Argentina isn’t the only team that’s scored big lately. $MDGL pulled off a hat trick by more than tripling in pre-market and continuing to drive higher throughout the day. πŸš€

Analysts attribute today’s massive price spike to the test results of a treatment for nonalcoholic steatohepatitis – NASH. NASH is a progressive disease that causes fibrosis – inflammation of the liver.

The test was completed with 950 NASH diagnoses patients. After one year, 30% of patients on the highest dose saw a two-point (out of eight total points) improvement in their symptoms. Additionally, their fibrosis did not become worse.

In another 26% of patients, at least one stage (out of five stages of fibrosis) improved with no increase in their symptoms.

Madrigal is requesting FDA approval for its oral treatment (pill), Resmetirom.Β 

After years of failures to find treatment for this disease, Madrigal’s would be the first to hit the market. πŸ’‰

AI’s Copyright Crisis Begins

We all knew copyright law would be a key issue at the heart of the artificial intelligence (AI) revolution, but we didn’t know when. Well, the time has come. βŒ›

Today, The New York Times filed a lawsuit against Microsoft and OpenAI, accusing them of infringing copyright and abusing the newspaper’s intellectual property. In its court filing, the publisher said it looks to hold the two companies accountable for the “unlawful copying and use of The Times’s uniquely valuable works,” claiming billions in statutory and actual damages.

Read It

FanDuel Parent Lists On NYSE

The U.S. “degenerate economy” is getting its latest entrant, with FanDuel parent company Flutter Entertainment making its debut on the New York Stock Exchange (NYSE) today. 🀩

With that said, the company did not receive the traditional fanfare it would in a standard initial public offering (IPO). That’s because it was listed on the London Stock Exchange (LSE) in May 2019, and its American depository receipts (ADR) have traded over the counter under the ticker $PDYPY for years.

Read It

Adobe Leads Day Of Breakups

Most of today’s stories were related to hookups in the market, but we also need to touch on some major breakups. πŸ’”

The first and most prevalent news story was that Adobe and Figma have called off their $20 billion acquisition. The two companies have faced intense scrutiny from European regulators, today saying, “There is no clear path to receive necessary regulatory approvals from the European Commission and the U.K. Competition and Markets Authority.” ❌

Read It

Investors Are Losing Trust

It’s been a rough eighteen months or so for real estate investment trusts (REITs), with higher interest rates giving investors alternative sources of yield and pressuring commercial real estate’s asset values. Unfortunately for Medical Properties Trust (MPT), that pain continuesΒ today, with its shares falling back to their Great-Financial-Crisis lows. 😬

The medical-related real estate property operator revealed to investors that one of its tenants, Steward Health Care System, is roughly $50 million behind in rent payments. As a result, MPT will take a $225 million noncash charge to write off rent receivables and other items.Β 

Read It